CPLX2 and lung neuroendocrine neoplasm: Komatsu et al. identified that CPLX2, a potential biomarker for high-level human lung neuroendocrine tumors (L-NETs), was significantly down-regulated in L-NETs, and its high expression was associated with lymphatic infiltration, pathological stage and survival [47].